1st June 2006

A collaboration between Mark Godber, Andrew Wilson, and John Goodby at York University with Gary Liney at the MRI Centre at Hull Royal Infirmary and Andy Beavis at Princess Royal Hospital, Hull has resulted in the development of imaging gels for use in 3D dosimetry in the radiotherapy treatment of cancer. Pre-polymer treated gels have been designed as artificial patients or phantoms, so that they can be written on by a high intensity X-ray source. The ensuing photopolymerisation reaction creates a polymer web, the extent of which can be read by MRI or optical scanning methods, thereby creating a 3D dosage profile for the X-rays delivered by linear accelerators (LINACS) used in radiotherapy treatments. The products of this research will be available through Imagel Ltd, a company set-up through the University of York, to market the gels commercially.

More News...

Click on highlighted date to view news.